Skip to main content

Clinical and Experimental Medicine

Ausgabe 5/2023

Inhalt (35 Artikel)

Open Access Review Article

Role of chemokines in the crosstalk between tumor and tumor-associated macrophages

Rui Qin, Weihong Ren, Guoqi Ya, Bei Wang, Jiao He, Shaoxin Ren, Lu Jiang, Shuo Zhao

Review Article

The role and function of CLU in cancer biology and therapy

Yefei Zhang, Xiang Lv, Liming Chen, Yan Liu

Review Article

Calreticulin as a marker and therapeutic target for cancer

Meilan Zhang, Juan Xiao, Jiangrong Liu, Xue Bai, Xuemei Zeng, Zhiwei Zhang, Feng Liu

Review

Targeting redox regulation and autophagy systems in cancer stem cells

Sameer Ullah Khan, Sheikh Rayees, Pankaj Sharma, Fayaz Malik

Review

The multifaceted role of MUC1 in tumor therapy resistance

Weiqiu Jin, Mengwei Zhang, Changzi Dong, Lei Huang, Qingquan Luo

Review Article

Prognostic and clinicopathological values of LINC00665 in cancers: a systematic review and China population-based meta-analysis

Ze Jin, Ya-Jun Meng, Yu-Shuang Xu, Meng-Meng Wang, Di Chen, Xin Jiang, Zhi-Fan Xiong

Review Article

Comparative efficacy and safety of first-line neoadjuvant treatments in triple-negative breast cancer: systematic review and network meta-analysis

Jinming Li, Guoshuang Shen, Miaozhou Wang, Xingfa Huo, Fuxing Zhao, Dengfeng Ren, Yi Zhao, Jiuda Zhao

Review Article

Effect of erythropoiesis-stimulating agents on breast cancer patients: a meta-analysis

Tong Wu, Zhenhua Tong, Tianshu Ren, Danni Xie, Xue Sun

Open Access Review

External radiotherapy combined with sorafenib has better efficacy in unresectable hepatocellular carcinoma: a systematic review and meta-analysis

Han Li, Zhenying Wu, Jiali Chen, Ke Su, Lu Guo, Ke Xu, Tao Gu, Yi Jiang, Pan Wang, Hao Zeng, Hao Chi, Kun He, Yunwei Han

Open Access Review Article

The prognostic effects of circulating myeloid-derived suppressor cells in non-small cell lung cancer: systematic review and meta-analysis

Giuseppe Bronte, Luana Calabrò, Fabiola Olivieri, Antonio Domenico Procopio, Lucio Crinò

Open Access Original Article

Immune checkpoint inhibition improves antimyeloma activity of bortezomib and STING agonist combination in Vk*MYC preclinical model

Olga Sokolowska, Anna Rodziewicz-Lurzynska, Zofia Pilch, Hanna Kedzierska, Justyna Chlebowska-Tuz, Anna Sosnowska, Anna Szumera-Cieckiewicz, Kamil Sokol, Joanna Barankiewicz, Aleksander Salomon-Perzynski, Olga Ciepiela, Ewa Lech-Maranda, Jakub Golab, Dominika Nowis

Open Access Original Article

Efficacy and safety analysis of bortezomib-based triplet regimens sequential lenalidomide in newly diagnosed multiple myeloma patients

Qiaolin Zhou, Fang Xu, Jingjing Wen, Jing Yue, Ya Zhang, Jing Su, Yiping Liu

Open Access Original Article

NCX1 disturbs calcium homeostasis and promotes RANKL-induced osteoclast differentiation by regulating JNK/c-Fos/NFATc1 signaling pathway in multiple myeloma

Tingting Li, Dongbiao Qiu, Qingjiao Chen, Apeng Yang, Junmin Chen, Zhiyong Zeng

Research

Bim downregulation by activation of NF-κB p65, Akt, and ERK1/2 is associated with adriamycin and dexamethasone resistance in multiple myeloma cells

Masanobu Tsubaki, Tomoya Takeda, Takuya Matsuda, Kana Kishimoto, Remi Tanaka, Katsumasa Tsurushima, Toshihiko Ishizaka, Shozo Nishida

Original Article

Risk factors and prognostic nomogram for patients with second primary cancers after lung cancer using classical statistics and machine learning

Lianxiang Luo, Haowen Lin, Jiahui Huang, Baixin Lin, Fangfang Huang, Hui Luo

Original Article

miR-548 predicts clinical prognosis and functions as a tumor promoter in gastric cancer

Guoyan Chen, Jingjuan Shang, Minhong Li, Huijun Zhang, Hui Xu

Open Access Original Article

Overexpression in metastatic breast cancer supports Syndecan-1 as a marker of invasiveness and poor prognosis

Bruna Cerbelli, Annalinda Pisano, Maria Gemma Pignataro, Angelina Pernazza, Andrea Botticelli, Mariantonia Carosi, Leopoldo Costarelli, Matteo Allegretti, Giulia d’Amati, Iole Cordone

Original Article

Watson for oncology decision system for treatment consistency study in breast cancer

Yaobang Liu, Xingfa Huo, Qi Li, Yishuang Li, Guoshuang Shen, Miaozhou Wang, Dengfeng Ren, Fuxing Zhao, Zhen Liu, Jiuda Zhao, Xinlan Liu

Original Article

Adult-onset Still’s disease and fever of unknown origin in India

Ashok Kumar Pannu, Vidhi Singla, Vikas Suri, Rajender Kumar, Yamini Mathur, Ritin Mohindra, Sanjay Jain

Original Article

Association analysis of miRNA-146a and miRNA-499 polymorphisms with rheumatoid arthritis: a case–control and trio-family study

Zia Ul Islam, Umul Baneen, Taqdees Khaliq, Syed Muhammad Nurulain, Zahid Muneer, Sabir Hussain

Original Article

Assessment of anti-nucleosome antibody (ANuA) isotypes for the diagnosis and prediction of systemic lupus erythematosus and lupus nephritis activity

Yanli Zeng, Yun Xiao, Fanxiang Zeng, Longcan Jiang, Shuidi Yan, Xuelian Wang, Qiaoduan Lin, Liang Yu, Xinxin Lu, Yan Zhang, Yiqiang Lin

Original Article

CYP51-mediated cholesterol biosynthesis is required for the proliferation of CD4+ T cells in Sjogren’s syndrome

Junhao Yin, Jiayao Fu, Yanxiong Shao, Jiabao Xu, Hui Li, Changyu Chen, Yijie Zhao, Zhanglong Zheng, Chuangqi Yu, Lingyan Zheng, Baoli Wang

Research

Role of kinurenic acid in the systemic sclerosis renal involvement

Chiara Pellicano, Valentina Vaiarello, Amalia Colalillo, Antonietta Gigante, Francesco Iannazzo, Edoardo Rosato

Research

Increased oxidative and chromosomal DNA damage in patients with ankylosing spondylitis: its role in pathogenesis

Funda Kiranatlioglu-Firat, Huseyin Demir, Isa Cuce, Pinar Altın-Celik, Hamiyet Eciroglu, Fahri Bayram, Hamiyet Donmez-Altuntas

Research

Diagnostic serum biomarkers associated with ankylosing spondylitis

Huan Li, Liang Wang, Jing Zhu, Jialing Xiao, Huining Yang, Huanyue Hai, Jiarui Hu, Lin Li, Yi Shi, Man Yu, Ping Shuai, Yuping Liu, Xueming Ju, Gang Wu, Yu Zhou, Bolin Deng, Bo Gong

Original Article

Efficacy of fibrates in the treatment of primary biliary cholangitis: a meta-analysis

Haifu Zhang, Shuojun Li, Yonghang Feng, Qinxia Zhang, Biyun Xie

Original Article

Untargeted metabolomics identifies potential serum biomarkers associated with Crohn’s disease

Bo Chen, Yongjun Wang, Qing Wang, Dingqi Li, Xiaotan Huang, Xiaojin Kuang, Shuzhong Wang, Zhaotun Hu

Open Access Original Article

Impact of gut Microbiome alteration in Ulcerative Colitis patients on disease severity and outcome

Osama Mohammed Basha, Raghda A. Hafez, Sara Mohamed Salem, Reham H. Anis, Amr Shaaban Hanafy

Original Article

Intravenous immunoglobulin therapy in immunoglobulin A vasculitis with gastrointestinal tract involvement

Nimet Öner, Elif Çelikel, Zahide Ekici Tekin, Vildan Güngörer, Tuba Kurt, Pakize Nilüfer Tekgöz, Müge Sezer, Cüneyt Karagöl, Serkan Coşkun, Melike Mehveş Kaplan, Merve Cansu Polat, Banu Çelikel Acar

Original Article

The top 100 most cited articles in anaphylaxis: a bibliometric analysis

Yu Song, Lishan Zhang, Yongshi Yang, Jinlyu Sun

Original Article

Diminished PD-L1 regulation along with dysregulated T lymphocyte subsets and chemokine in ANCA-associated vasculitis

Jagdeep Singh, Ranjana Walker Minz, Biman Saikia, Ritambhra Nada, Aman Sharma, Saket Jha, Shashi Anand, Manish Rathi, Sanjay D’Cruz

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.